DJIA 17,077.96 134.15 0.79%
NASDAQ 4,445.90 30.41 0.69%
S&P 500 1,979.31 11.74 0.60%
market minute promo

3.10 0.15 (5.08%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

PSTI $3.10 5.08%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.15
Previous Close $2.95
Daily Range $3.08 - $3.15
52-Week Range $2.85 - $4.63
Market Cap $210.5M
P/E Ratio -6.56
Dividend (Yield) $0.00 (0.0%)
Volume 115,691
Average Daily Volume 136,272
Current FY EPS -$0.48






Pluristem Therapeutic is a bio-therapeutics Company dedicated to the commercialization of non-personalized cell therapy products for the treatment of several severe degenerative ischemic and autoimmune disorders. Website:

News & Commentary Rss Feed

Why Sinovac, Pluristem, and Synta Could Be Worth Watching Today

Sinovac, Pluristem, and Synta Pharmaceuticals might all be worth a look today. Let's take a look at the headlines that could move these three stocks.

NIH's Human Placenta Project Is Validation For Placental Cells Curing Deadly Diseases

Pluristem Initiates Trial in South Korea - Analyst Blog

Pluristem Initiates Trial in South Korea - Analyst Blog

Israeli Biomed-Tech Companies Present Investment Opportunities

Morning Gainers for Mar. 6, 2014: PXLW, SGMO, ERII, RGSE, NAVB, PSTI

Sector Update: Healthcare Shares Edging Higher in Pre-Bell Trade

Sector Update: Healthcare

Pluristem's Preeclampsia Effort Pushes PLX Platform

Pipeline Progress at Pluristem - Analyst Blog

Pipeline Progress at Pluristem - Analyst Blog

Will Regeneron (REGN) Disappoint in Q4? - Analyst Blog

Company news for February 05, 2014 - Corporate Summary

See More PSTI News...

PSTI's Top Competitors

PSTI $3.10 (5.08%)
Current stock: PSTI
AMGN $119.75 (-0.02%)
Current stock: AMGN
GILD $90.02 (1.45%)
Current stock: GILD
BIIB $324.10 (0.58%)
Current stock: BIIB